Jiajie Leng

Dr. Jiajie Leng


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2024 in Medicine
Verified
Journal Article
Open access
JLJiajie Leng
Jiajie Leng
LLLi Letai
Li Letai
HTHongwen Tu
Hongwen Tu
YLYuxiang Luo
Yuxiang Luo
ZCZhenrui Cao
Zhenrui Cao
YJYingjiu Jiang
Yingjiu Jiang
Acute kidney injury (AKI) is a common postoperative complication, but there is still a lack of accurate biomarkers. Cardiac surgery-associated AKI is the most common cause of major-surgery-related AKI, and patients requiring renal replacement therapy have high mortality rates. Early diagnosis, intervention, and management are crucial for improving patient prognosis. However, diagnosing AKI based solely on changes in serum creatinine level and urine output is insufficient, as these changes often lag behind actual kidney damage, making early detection challenging. Biomarkers such as tissue inhibitor of metalloproteinases-2 (TIMP-2) and insulin-like growth factor-binding protein-7 (IGFBP-7) have been found to be significant predictors of moderate-to-severe AKI when combined with urine content analysis. This article reviews the mechanism of biomarkers TIMP-2 and IGFBP-7 in AKI and provides a comprehensive overview of the clinical effects of TIMP-2 and IGFBP-7 in cardiac surgery-associated AKI, including prediction, diagnosis, and progression.


18 November 2025 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
LLLetai Li
Letai Li
HWHaiyan Wang
Haiyan Wang
YCYutong Chen
Yutong Chen
XTXinlin Tan
Xinlin Tan
TGTing Gao
Ting Gao
JLJiajie Leng
Jiajie Leng
Objective: To assess the global burden, trends, and inequalities of pulmonary arterial hypertension (PAH) among women of childbearing age (WCBA) from 1990 to 2021, projecting future trends to 2040. Methods: Using Global Burden of Disease (GBD) 2021 data, we analyzed PAH mortality, incidence, prevalence, and disability-adjusted life years (DALYs) among WCBA aged 15 to 49. Trends were assessed via age-standardized rates (ASR), estimated annual percentage change (EAPC), joinpoint regression, decomposition, and inequality analyses. Future burden was projected using Bayesian age-period-cohort, auto-regressive moving average, and exponential smoothing models. Results: The absolute number of PAH cases among WCBA increased globally from 1990 to 2021. Critically, the global age-standardized incidence rate (ASIR) showed a neglected upward trend (EAPC = 0.12), while mortality and DALY rates declined. Significant inequalities were observed, with the ASIR highest in low-middle SDI regions and prevalence highest in high SDI regions. Decomposition analysis identified population growth as the primary driver of increasing burden in low-resource settings. Projections indicate a continued rise in incidence by 2040, alongside declining mortality. Conclusion: This study demonstrated a persistent and growing PAH burden among WCBA, marked by significant inequalities. The rising incidence, particularly in low-resource settings, coupled with the cumulative prevalence in high-income regions, underscores an urgent need for targeted public health actions. Region-specific interventions are vital, including integrating PAH screening into maternal health programs in resource-poor settings and optimizing long-term management in high-income countries.

12 February 2024 in International Journal of Surgery
Verified
Journal Article
Open access
YLYuxiang Luo
Yuxiang Luo
JLJiajie Leng
Jiajie Leng
RSRui Shi
Rui Shi
YJYingjiu Jiang
Yingjiu Jiang
CDChen Dan
Chen Dan
HTHongtao Tie
Hongtao Tie
Introduction: This study aims to investigate the effect of concomitant tricuspid valve surgery (TVS) during left ventricular assist device (LVAD) implantation due to the controversy over the clinical outcomes of concomitant TVS in patients undergoing LVAD. Methods: A systematic literature search was performed in PubMed and EMbase from the inception to 1 August 2023. Studies comparing outcomes in adult patients undergoing concomitant TVS during LVAD implantation (TVS group) and those who did not (no-TVS group) were included. The primary outcomes were right heart failure (RHF), right ventricular assist device (RVAD) implantation, and early mortality. All meta-analyses were performed using random-effects models, and a two-tailed P<0.05 was considered significant. Results: Twenty-one studies were included, and 16 of them were involved in the meta-analysis, with 660 patients in the TVS group and 1291 in the no-TVS group. Patients in the TVS group suffered from increased risks of RHF [risk ratios (RR)=1.31, 95% CI: 1.01–1.70, P=0.04; I 2=38%, p H =0.13), RVAD implantation (RR=1.56, 95% CI: 1.16–2.11, P=0.003; I 2=0%, p H =0.74), and early mortality (RR=1.61, 95% CI: 1.07–2.42, P=0.02; I 2=0%, p H =0.75). Besides, the increased risk of RHF holds true in patients with moderate to severe tricuspid regurgitation (RR=1.36, 95% CI: 1.04–1.78, P=0.02). TVS was associated with a prolonged cardiopulmonary bypass time. No significant differences in acute kidney injury, reoperation requirement, hospital length of stay, or ICU stay were observed. Conclusions: Concomitant TVS failed to show benefits in patients undergoing LVAD, and it was associated with increased risks of RHF, RVAD implantation, and early mortality.

1 January 2025 in Cardiovascular Innovations and Applications
Verified
Journal Article
Open access
PDF file
KZKun Zhou
Kun Zhou
YJYingjiu Jiang
Yingjiu Jiang
JLJiajie Leng
Jiajie Leng
It explored the causal PANoptosis genes with DNA methylation regulated as the potential therapeutic targets. What is the main novel finding? This study provides novel insights into PANoptosis genes (BCL2L1 and UBC) regulating MI through DNA methylation.

23 January 2026 in Medicine
Verified
Journal Article
Open access
ZSZhuoxuan Song
Zhuoxuan Song
LLLetai Li
Letai Li
AHAiwei He
Aiwei He
TCTingting Chen
Tingting Chen
RLRongjia Liu
Rongjia Liu
JLJiajie Leng
Jiajie Leng
The Mediterranean diet exerts beneficial effects on cardiovascular health, though many of its underlying mechanisms remain undefined. While omega-3/6 polyunsaturated fatty acids (PUFAs) present in this dietary pattern may influence cardiac inflammatory conditions, their specific roles in heart diseases require further investigation. Independent single nucleotide polymorphisms associated with omega-3/6 PUFAs and 3 cardiac inflammatory diseases were identified through the IEU Open Genome-Wide Association Study database. Mendelian randomization (MR) analysis was employed to assess potential causal relationships between PUFAs and endocarditis, myocarditis, and pericarditis. The primary analytical approach utilized inverse variance weighting (IVW), complemented by weighted median and MR-Egger methods. Sensitivity analyses included Cochran Q test, MR-pleiotropy residual sum and outlier, MR-Egger regression, and leave-one-out analysis to evaluate heterogeneity and potential pleiotropic effects. IVW analysis revealed a positive causal association between omega-6 PUFAs and myocarditis risk ( P -IVW = .013). No statistically significant genetic associations were observed between omega-6 PUFAs and endocarditis or pericarditis. Similarly, omega-3 PUFAs showed no significant causal relationships with any of the 3 inflammatory cardiac conditions. Sensitivity analyses confirmed the absence of horizontal pleiotropy across all findings. This MR study identifies omega-6 fatty acids as a significant class of PUFAs potentially contributing to myocarditis pathogenesis. These findings highlight the need for further investigation into the pro-inflammatory properties of specific PUFAs in cardiac pathophysiology.